IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Logos Global Management LP

Q2 2025 Holdings

Filed 2025-08-14 | 51 holdings | $903.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr Series Trust(XBI)CallS&P BIOTECH78464A870$82.9M1,000,0009.2%
Ideaya Biosciences Inc(IDYA)COM45166A102$70.3M3,345,0007.8%
Akero Therapeutics Inc(AKRO)COM00973Y108$64.0M1,200,0007.1%
Revolution Medicines Inc(RVMD)COM76155X100$62.5M1,700,0006.9%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$47.8M450,0005.3%
Disc Medicine Inc(IRON)COM254604101$37.1M700,0004.1%
Avidity Biosciences Inc(RNA)COM05370A108$27.0M950,0003.0%
Keros Therapeutics Inc(KROS)COM492327101$26.7M2,000,0003.0%
Teva Pharmaceutical Inds LTD(TEVA)CallSPONSORED ADS881624209$25.1M1,500,0002.8%
Biogen Inc(BIIB)COM09062X103$25.1M200,0002.8%
United Therapeutics Corp del(UTHR)COM91307C102$24.4M85,0002.7%
Arvinas Inc(ARVN)COM04335A105$24.3M3,300,0002.7%
Janux Therapeutics Inc(JANX)COM47103J105$23.1M1,000,0002.6%
Ocular Therapeutix Inc(OCUL)COM67576A100$20.4M2,200,0002.3%
Erasca Inc(ERAS)COM29479A108$19.1M15,000,0002.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$18.9M150,0002.1%
Dyne Therapeutics Inc(DYN)COM26818M108$18.1M1,900,0002.0%
Immunocore Hldgs PLC(IMCR)ADS45258D105$18.0M575,0002.0%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$17.6M850,0002.0%
Apellis Pharmaceuticals Inc(APLS)CallCOM03753U106$17.3M1,000,0001.9%
Madrigal Pharmaceuticals Inc(MDGL)COM558868105$15.1M50,0001.7%
Design Therapeutics Inc(DSGN)COM25056L103$14.2M4,217,6271.6%
Krystal Biotech Inc(KRYS)COM501147102$13.7M100,0001.5%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$13.7M3,208,8751.5%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$12.2M600,0001.4%
Janux Therapeutics Inc(JANX)CallCOM47103J105$11.6M500,0001.3%
Arvinas Inc(ARVN)CallCOM04335A105$11.0M1,500,0001.2%
Biohaven LTD(BHVN)COMG1110E107$9.9M700,0001.1%
Xencor Inc(XNCR)COM98401F105$9.8M1,250,0001.1%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$9.5M225,0001.0%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$9.4M200,0001.0%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$9.3M190,0001.0%
Crescent Biopharma Inc.(CBIO)COMG2545C104$8.9M553,6861.0%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$8.9M250,0001.0%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$8.2M130,0000.9%
Maze Therapeutics Inc(MAZE)COM578784100$7.5M611,9140.8%
Larimar Therapeutics Inc(LRMR)CallCOM517125100$7.2M2,500,0000.8%
Enliven Therapeutics Inc(ELVN)COM29337E102$7.0M350,0000.8%
Jade Biosciences Inc(JBIO)COM NEW008064206$6.2M625,0000.7%
Annexon Inc(ANNX)COM03589W102$5.8M2,410,0000.6%
Metsera IncCOM59267L107$5.7M200,0000.6%
Trevi Therapeutics Inc(TRVI)COM89532M101$4.6M850,0000.5%
Immunovant Inc(IMVT)COM45258J102$4.4M275,0000.5%
Verastem Inc(VSTM)COM NEW92337C203$4.2M1,000,0000.5%
Astria Therapeutics Inc(CATBUSD)COM04635X102$3.8M700,0000.4%
Bicara Therapeutics Inc(BCAX)COM055477103$3.7M400,0000.4%
Aclaris Therapeutics Inc(ACRS)COM00461U105$2.6M1,850,0000.3%
Rapport Therapeutics Inc(RAPP)COM75383L102$2.4M208,9100.3%
Unicycive Therapeutics Inc(UNCY)COM NEW90466Y202$2.3M473,5620.2%
Septerna Inc(SEPN)COM81734D104$1.2M109,2020.1%
Page 1 of 2Next